Abstract

Many trials have now shown that low-dose heparin reduces the incidence of deep-vein thrombosis.^1,2 In addition evidence from lung-perfusion studies suggests that such prophylaxis will also reduce the 1% mortality normally associated with major general surgery.^3,4